Skip to main content

Advertisement

Log in

Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Psoriasis is associated with obesity accompanied by insulin resistance. A recent study disclosed increased plasma resistin and decreased plasma omentin levels in obesity. Few studies of plasma levels of resistin and omentin are available in psoriasis. We analyzed plasma levels of resistin and omentin in psoriasis and compared them with those of healthy controls. Evaluation of plasma levels of resistin and omentin was performed by enzyme-linked immunosorbent assay (ELISA) for 62 psoriasis patients and 58 healthy controls. The severity of psoriasis was evaluated by psoriasis area and severity index (PASI) score. Plasma levels of resistin were significantly increased in psoriasis as compared with those of healthy controls. In contrast, plasma levels of omentin were significantly decreased in psoriasis patients. Plasma levels of resistin and omentin were positively and negatively correlated with PASI scores, respectively. After the treatment of psoriasis, resistin levels were decreased and omentin levels were increased, respectively, compared with those of pretreated. Plasma levels of resistin and omentin might be useful for evaluating the disease activity of psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, Boehncke WH (2007) Psoriasis patients show signs of insulin resistance. Br J Dermatol 157:1249–1251

    Article  PubMed  CAS  Google Scholar 

  2. Gerdes S, Rostami-Yazdi M, Mrowietz U (2011) Adipokines and psoriasis. Exp Dermatol 20:81–87

    Article  PubMed  CAS  Google Scholar 

  3. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263–271

    Article  PubMed  CAS  Google Scholar 

  4. Henseler T, Christohpers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986

    Article  PubMed  CAS  Google Scholar 

  5. Johnston A, Arnadottir S, Gudjonsson JE, Aphale A, Sigmarsdottir A, Gunnarsson SI, Steinsson JT, Elder JT, Valdimarsson H (2008) Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 159:342–350

    Article  PubMed  CAS  Google Scholar 

  6. Kawashima K, Torii K, Furuhashi T, Saito C, Nishio E, Nishida E, Shintani Y, Morita A (2011) Phototherapy reduces serum resistin levels in psoriasis patients. Photodermatol Photoimmunol Photomed 27:152–155

    Article  PubMed  Google Scholar 

  7. Kralisch S, Klein J, Bluher M, Paschke R, Stumvoll M, Fasshauer M (2005) Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother 6:863–872

    Article  PubMed  CAS  Google Scholar 

  8. Nakajima H, Nakajima K, Tarutani M, Morishige R, Sano S (2011) Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 303:451–455

    Article  PubMed  CAS  Google Scholar 

  9. Schaffler A, Neumeier M, Herfart H, Furst A, Scholmerich J, Buchler C (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental tissue. Biochim Biophys Acta 1732:96–102

    Article  PubMed  CAS  Google Scholar 

  10. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:899–912

    Article  Google Scholar 

  11. Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661

    Article  PubMed  Google Scholar 

  12. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H (2009) Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis. J Dermatol Sci 54:61–63

    Article  PubMed  Google Scholar 

  13. Takahashi H, Takahashi I, Honma M, Ishida-Yamamoto A, Iizuka H (2011) The prevalence of metabolic syndrome in the Japanese psoriasis patients. J Dermatol Sci 57:143–144

    Article  Google Scholar 

  14. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H (2008) Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 159:1207–1208

    PubMed  CAS  Google Scholar 

  15. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Kohrt WM, Fried SK, McLenithan JC, Gong DW (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin actin. Am J Physiol Endocrinol Metab 290:E1253–E1261

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hidetoshi Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, H., Tsuji, H., Honma, M. et al. Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis. Arch Dermatol Res 305, 113–116 (2013). https://doi.org/10.1007/s00403-012-1310-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1310-9

Keywords

Navigation